- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02665663
Tongue Strength in Amyotrophic Lateral Sclerosis (ALS)
Measure of the Strength of the Tongue in Patients With Amyotrophic Lateral Sclerosis and Relation With Swallowing Disorders
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease with a poor prognosis that occurs in adults 64 years on average. Its prevalence is 4 to 6/100 000 inhabitants.
Swallowing disorders occur during evolution and involve the prognosis of patients in the short term by the association of dysphagia with severe malnutrition, and aspiration. The issue of phoniatric monitoring is to detect early onset of the swallowing disorders to develop strategies for respiratory protection, food adapted to disturbances, and speech therapy.
The objective of this study is to compare the tongue force in patients with amyotrophic lateral sclerosis at the time of diagnosis and at the onset of swallowing disorders compared to healthy subjects, with the dynamic palatography device developed in the Laboratoire Parole et Langage (UMR 7309, CNRS-Université Aix-Marseille, Aix-en-Provence), which allows the measurement of the strength and duration of the pression of the tongue on the palate.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Aude LAGIER, MCU-PH
- Phone Number: 04 91 38 60 71
- Email: aude.lagier@ap-hm.fr
Study Locations
-
-
-
Marseille, France, 13005
- Service ORL Assistance Publique Hôpitaux de Marseille
-
Contact:
- Aude LAGIER, MCU-PH
- Phone Number: 04 91 38 60 71
- Email: aude.lagier@ap-hm.fr
-
Principal Investigator:
- Aude LAGIER, MCU-PH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults and legally responsible/ valid medical insurance
- patients : ALS diagnostic already announced
- healthy subjects : EAT-10 score<2
Exclusion Criteria:
- Non pregnant and non baby feeding
- Presence of risk factor or suspicion of Creutzfeld Jacob Disease
- Allergy/intolerance to the glueing paste
- Antecedent of pathology of the aerodigestive tract
- Other neurologic disease
- Morphologic anomaly of the aerodigestive tract
- Excessive gag reflex
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: healthy volunteers
Constitution of a control group consisting of 20 healthy volunteers, matched for age and sex to establish a "normal" pressure force of the language depending on the age and sex value
|
|
Other: Patients with Amyotrophic Lateral Sclerosis
Constitution of a group of 20 patients with Amyotrophic Lateral Sclerosis (ALS), included at diagnosis of the disease on clinical and electromyographic arguments addressed in speech pathology consultation without a complaint swallowing.
|
|
Other: patients with Amyotrophic Lateral Sclerosis and swallowi
Constitution of a group of 20 patients with Amyotrophic Lateral Sclerosis ( ALS) and swallowing disorders clinically objectified in the ENT consultation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximum tongue strength
Time Frame: 30 minutes
|
maximal tongue strength during salivary swallowing
|
30 minutes
|
Tongue contact duration
Time Frame: 30 minutes
|
Duration of tongue and palate contact during salivary
|
30 minutes
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-18
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amyotrophic Lateral Sclerosis
-
Washington University School of MedicineMassachusetts General HospitalSuspendedAmyotrophic Lateral Sclerosis, Familial | Amyotrophic Lateral Sclerosis, SporadicUnited States
-
University of Sao Paulo General HospitalPontifícia Universidade Católica do ParanáUnknownAMYOTROPHIC LATERAL SCLEROSISBrazil
-
Neuromed IRCCSRecruitingAmyotrophic Lateral Sclerosis (ALS)Italy
-
Humanitas Mirasole SpAKU Leuven; UMC Utrecht; University of Sheffield; Istituto Superiore di Sanità; University... and other collaboratorsActive, not recruitingAmyotrophic Lateral Sclerosis (ALS)United Kingdom, Germany, France, Netherlands, Belgium, Ireland, Italy
-
The Methodist Hospital Research InstituteMassachusetts General Hospital; The Center for Clinical and Translational Sciences... and other collaboratorsActive, not recruiting
-
CytokineticsCompletedAmyotrophic Lateral Sclerosis (ALS)United States, Netherlands, Canada, Belgium, United Kingdom, France, Germany, Ireland, Italy, Portugal, Spain
-
Columbia UniversityALS AssociationTerminatedAmyotrophic Lateral Sclerosis (ALS)United States
-
El Instituto Nacional de Neurologia y Neurocirugia...CompletedAmyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis, SporadicMexico
-
University Hospital, GenevaCompletedAmyotrophic Lateral Sclerosis 11Switzerland
-
Fondazione Don Carlo Gnocchi OnlusFondazione Salvatore MaugeriCompleted
Clinical Trials on medical device
-
Karolinska University HospitalCompleted
-
Fondazione Don Carlo Gnocchi OnlusFondazione Ico FalckNot yet recruitingMultiple Sclerosis | Parkinson Disease | Post-stroke
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); University of MinnesotaCompletedCurrent Every Day Smoker | Cigarette SmokerUnited States
-
Reckitt Benckiser LLCCompleted
-
University Health Network, TorontoUnknown
-
University Hospital, GrenobleCommissariat A L'energie AtomiqueRecruitingHealthy Volunteers | Parkinson's Disease Patients | Para/Tetraplegic PatientsFrance
-
Prof Henry KrumHD Medical Group LtdTerminatedCardiovascular DiseasesAustralia
-
Lawson Health Research InstituteNot yet recruitingMedical Devices | Open Access | Low Cost | ElectrocardiographCanada
-
Karolinska InstitutetKällmark ClinicCompletedKeratoconjunctivitis Sicca (KCS)Sweden
-
A.M.I. Agency for Medical Innovations GmbHRecruitingFecal IncontinenceSpain, Austria, Germany